The Centers for Disease Control and Prevention Oct. 23 released interim guidance for clinicians with limited access to the monoclonal antibody nirsevimab, recently approved to prevent respiratory syncytial virus in children aged 2 and under.
News
Latest
The share of health workers who reported feeling threatened or harassed by patients or others at work more than doubled between 2018 and 2022 to 13.4%, according to a new Centers for Disease Control and Prevention report based on national survey data.
The Food and Drug Administration recently extended to 30 months the shelf life for certain lots of Gohibic (vilobelimab), authorized for emergency use to treat COVID-19 in certain hospitalized adults.
Hospital systems make it easier to access and coordinate care, according to a national survey of their patients conducted by Morning Consult for the AHA.
People visit hospitals to receive care for injuries or diseases or undergo needed medical procedures and surgeries.
Understand the impact of the Biden-Harris Administration's National Cybersecurity Strategy on health care and its relevance for hospitals and health systems. #BidenCybersecurity
Two leaders from South Dakota-based Monument Health discuss the rural health system’s health equity journey, which captured this year’s AHA Carolyn Boone Lewis Equity of Care Award for excellence in advancing health equity in rural or small communities.
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and other solid forms of prescription drugs.
The Cybersecurity and Infrastructure Security Agency, FBI and Multi-State Information Sharing and Analysis Center this week alerted organizations to a critical vulnerability affecting certain versions of the Atlassian Confluence Data Center and Server that enables malicious actors to obtain access to victim systems and continue active exploitation post-patch.
While telehealth use has skyrocketed these last few years, our laws have not kept up.
WellSpan Health’s Specialized Treatment and Recovery Team in York County, Pa., provides integrated care for patients considered too complex for conventional outpatient treatment or who require immediate access to car
The Department of Health and Human Services’ Office for Civil Rights Oct. 18 released a resource for health care providers who choose to educate patients about telehealth privacy and security, noting that the HIPAA rules do not require it.
AHA on Oct. 19 submitted a statement to the House Energy and Commerce Health Subcommittee on legislative proposals involving Medicare.
President and CEO John Chessare, M.D., shares how GBMC HealthCare began investing in its Baltimore community by specifically focusing on social determinants of health.
Physician-owned hospitals cherry-pick healthy and wealthy patients, provide limited emergency services and increase costs for patients, providers and the federal government, write AHA Executive Vice President Stacey Hughes and Federation of American Hospitals President and CEO Chip Kahn.
On Oct. 31 at 1 p.m. ET, the Food and Drug Administration will host a webinar to review its recent proposed rule for laboratory developed tests, which would amend the agency’s regulations to require most laboratory developed tests to meet the same medical device requirements as other in vitro diagnostic products.
The average annual premium for employer-sponsored family health coverage rose 7% in 2023 to $23,968, including employer and worker contributions, according to the latest annual survey by the Kaiser Family Foundation.
A new coalition, whose founding members include the AHA, will advocate for “common-sense solutions" to the severe staffing shortage plaguing the nation’s health care system
The American Heart Association has released a free two-hour accredited learning module on maternal cardiovascular risks and disparities to help clinicians address the leading cause of maternal mortality and improve outcomes for pregnant and recently pregnant individuals in their care.
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response recently awarded over $500 million to prepare for clinical trial three COVID-19 vaccine candidates that target better or longer-lasting immune response; increase central laboratory capacity for sample testing; and investigate better ways to develop monoclonal antibodies and evaluate and administer vaccines.